The presence of specific immune cells within the tumor tissue, such as increased densities of T cell infiltrates with a high proportion of CD8+ T and demonstrated that immune reactivity at the tumor site influences clinical outcome [92]. This evidence concerns the gene CD8A and neoplasm.